Certara Announces Update of D360™ Scientific Informatics Software
“State of the art intelligence technology for scientific informatics disciplines, like the D360 software, is a fundamental building block for the next generation digitalization,” said
Certara’s D360 scientific informatics software is used globally by more than 6,000 discovery research scientists at biopharmaceutical and biotechnology companies, including five of the top 10 by research and development spend. The D360 software delivers end-to-end access to data and integrated scientific intelligence, resulting in timelier insights and greater understanding of drug candidates.
New capabilities of Certara’s D360 software include:
- Biologic drugs: Support for visual sequence clustering and HELM (Hierarchical Editing Language for Macromolecules) version 2, which is widely adopted across the industry, and enhanced capabilities for sequence-activity relationship generation
- Small molecules: Transformation analysis, which allows scientists to understand the effect of structural changes over a range of assays and properties
- Workflows: Accelerated scientific decision-making using filter capabilities and multi-valued data fields
- Data visualization: Visualization of multi-parameter project progression and new details viewer mode for focus on specific aspects of a dataset to accelerate scientific workflows
“With the growing drug development pipeline for large molecule biologics and new ways to analyze small molecules, we are continuously innovating our D360 software to accommodate the accelerating requirements of discovery research,” said
Learn more about D360 scientific informatics software at https://www.certara.com/data-and-informatics/d360-scientific-informatics-platform/
About
Certara Contact:
jieun.choe@certara.com
Investor Relations Contact:
ir@certara.com
Media Contact:
ariane.lovell@finnpartners.com
Source: Certara